Medistim ASA
OSE:MEDI
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
NO |
Medistim ASA
OSE:MEDI
|
3.3B NOK | 24.9 | ||
US |
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 1 086.8 | ||
US |
Abbott Laboratories
NYSE:ABT
|
187.1B USD | 26.2 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
148.1B USD | 86.7 | ||
US |
Stryker Corp
NYSE:SYK
|
133.1B USD | 38.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
113.4B USD | 45.8 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110.2B USD | 16.2 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.9B USD | 18.6 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
61.5B EUR | 31.7 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53.1B USD | 59.2 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
362.5B CNY | 28.8 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.